Literature DB >> 11597765

Involvement of VIP on BDNF-induced somatostatin gene expression in cultured fetal rat cerebral cortical cells.

G Villuendas1, F Sánchez-Franco, N Palacios, M Fernández, L Cacicedo.   

Abstract

Previous studies have shown that BDNF promotes expression of SS. In earlier studies we demonstrated the stimulatory effect of locally produced VIP upon SS secretion. These facts led us to explore the peptidergic action of BDNF on VIP, and to determine if BDNF-induced SS might be mediated by the induction of VIP. Cultured fetal rat cerebrocortical cells were incubated with BDNF (50 ng/ml) and/or VIP (10(-11) M) for 2 and 5 days. In other experiments IgGs from BDNF or VIP antisera were also added. BDNF increased VIP and SS gene expression and peptide production. After 2 days of incubation with both BDNF and VIP the induction of SS mRNA was similar to that obtained with BDNF alone. However when the treatment was extended to 5 days the increase in SS mRNA was higher than that obtained with BDNF alone. This finding suggests the possibility that both factors acted synergistically. To define the potential role of VIP in the response of SS gene expression to BDNF, endogenous VIP was blocked with IgGs from VIP antiserum. Under these experimental conditions BDNF-induced SS decreased. Our study provides the first evidence that BDNF up-regulates VIP gene expression and concentration of the peptide. The involvement of VIP on BDNF-induced SS gene expression is also demonstrated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11597765     DOI: 10.1016/s0169-328x(01)00177-2

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  9 in total

1.  Stage-dependent BDNF serum concentrations in Alzheimer's disease.

Authors:  C Laske; E Stransky; T Leyhe; G W Eschweiler; A Wittorf; E Richartz; M Bartels; G Buchkremer; K Schott
Journal:  J Neural Transm (Vienna)       Date:  2005-12-16       Impact factor: 3.575

2.  Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia.

Authors:  J Wong; T M Hyde; H L Cassano; A Deep-Soboslay; J E Kleinman; C Shannon Weickert
Journal:  Neuroscience       Date:  2010-05-27       Impact factor: 3.590

Review 3.  The relationship between pubertal hormones and brain plasticity: Implications for cognitive training in adolescence.

Authors:  Corinna Laube; Wouter van den Bos; Yana Fandakova
Journal:  Dev Cogn Neurosci       Date:  2020-01-22       Impact factor: 6.464

4.  Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease.

Authors:  T Leyhe; Elke Stransky; G W Eschweiler; G Buchkremer; C Laske
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-11-07       Impact factor: 5.270

5.  Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder.

Authors:  Harvey M Morris; Takanori Hashimoto; David A Lewis
Journal:  Cereb Cortex       Date:  2008-01-17       Impact factor: 5.357

6.  Enriched Environment Reverts Somatostatin Interneuron Loss in MK-801 Model of Schizophrenia.

Authors:  Ane Murueta-Goyena; Naiara Ortuzar; José Vicente Lafuente; Harkaitz Bengoetxea
Journal:  Mol Neurobiol       Date:  2019-09-10       Impact factor: 5.590

7.  A pilot study of brain morphometry following donepezil treatment in mild cognitive impairment: volume changes of cortical/subcortical regions and hippocampal subfields.

Authors:  Gwang-Won Kim; Byeong-Chae Kim; Kwang Sung Park; Gwang-Woo Jeong
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

8.  Injury-associated PACAP expression in rat sensory and motor neurons is induced by endogenous BDNF.

Authors:  Lina M E Pettersson; Nicole M Geremia; Zhengxin Ying; Valerie M K Verge
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

Review 9.  Regulatory Mechanisms of Somatostatin Expression.

Authors:  Emmanuel Ampofo; Lisa Nalbach; Michael D Menger; Matthias W Laschke
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.